Published in Blood Weekly, October 5th, 2006
"The study was initially designed to differentiate human bone marrow-derived mesenchymal stem cells (MSC) into chondrocyte-like cells, for use in tissue engineering.
"We cultured MSCs in defined chondrogenic medium as pellet cultures supplemented with transforming growth factor (TGF)-beta 1 or -beta 3 and dexamethazone, as they are commonly used to promote in vitro chondrogenesis," scientists in Canada report.
According to F. Mwale and colleagues at McGill University in Montreal, "Markers of chondrogenesis used were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.